Albert B Deisseroth

Title: Innovations of Albert B Deisseroth in Cancer Treatment

Introduction

Albert B Deisseroth is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of cancer treatment through his innovative research and patents. His work primarily focuses on developing advanced therapeutic methods for chronic myeloid leukemia.

Latest Patents

Deisseroth holds a patent for "Liposomal antisense methyl phosphonate oligonucleotides and methods for." This patent describes a liposomal methyl phosphonate oligonucleotide composition that is useful in treating chronic myeloid leukemia. The composition includes a liposome containing at least one phospholipid and an antisense methyl phosphonate oligonucleotide entrapped within it. The molar ratio of phospholipid to methyl phosphonate in the liposome ranges from about 100:1 to about 10,000:1. The process for creating this composition involves several steps, including mixing the oligonucleotide with phospholipid in different organic solvents, lyophilizing the mixture, hydrating the resulting powder, and sonicating the hydrated material.

Career Highlights

Deisseroth is affiliated with the University of Texas System, where he continues to advance his research in the field of cancer therapeutics. His innovative approach to drug delivery systems has the potential to significantly improve treatment outcomes for patients suffering from chronic myeloid leukemia.

Collaborations

Some of his notable coworkers include Ana Maria Tari and Gabriel Lopez-Berestein. Their collaborative efforts contribute to the ongoing research and development of effective cancer treatments.

Conclusion

Albert B Deisseroth's work exemplifies the intersection of innovation and medical science. His patented methods for treating chronic myeloid leukemia highlight the importance of research in developing new therapeutic strategies. His contributions are paving the way for advancements in cancer treatment.